Enhanced casein kinase II (CK II) activity in human lung tumours


Yaylim I. , ISBIR T.

ANTICANCER RESEARCH, vol.22, pp.215-218, 2002 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22
  • Publication Date: 2002
  • Title of Journal : ANTICANCER RESEARCH
  • Page Numbers: pp.215-218
  • Keywords: casein kinase II, lung, cancer, EPIDERMAL GROWTH-FACTOR, 2 PROTEIN-KINASES, RABBIT RETICULOCYTES, SUBUNIT-ALPHA, CELL-LINE, PHOSPHORYLATION, SUBSTRATE, PURIFICATION, INITIATION, NUCLEOLIN

Abstract

Background: Casein kinase 11 (CK II) is expressed at a higher level in lung tumours when compared to the corresponding non-neoplastic lung tissue. Materials and Methods: The aim of the present study was to evaluate the activity of CK II both in neoplastic and non-neoplastic human lung tissue by using a synthetic peptide with Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp (RRRDDDSDDD) sequence. One unit of CK If activity is defined as the amount catalysing the transfer of I pmol P-32 into the substrate within I minute at 37degreesC. Results: The activities measured for the neoplastic and non-neoplastic tissues were 1250-1500 U/mg protein and 100-500 U/mg protein, respectively. According to these results, the maximum activity observed in the lung carcinomas was 2 to 3-fold higher than the lung tumour specimens when compared to the non-neoplastic lung tissue. The activity range of CK II was between 500-1500 U mg protein. Conclusion: Our results suggest that CK 11 plays an important role in cellular proliferation and the mechanism of its activation.